Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Dasatinib Overcomes AML Resistance to BCL2 Inhibition By Indirectly Inhibiting MCL1: From Ex Vivo drug Sensitivity/Resistance Profiling to a Phase II Clinical Trial: A Hemato-BIO Study

Sylvain Garciaz, Rémy Castellano, Arnaud Jacquel, Arnaud Guille, Maxence Bourgoin, Camille Montersino, José Adélaïde, Patrick Auberger, Daniel Birnbaum, Marie Anne Hospital, Yves Collette, Norbert Vey

Blood (2024) 144 (Supplement 1): 1378.

https://doi.org/10.1182/blood-2024-207352

Published: 2024

Journal Articles

Noncanonical EZH2 drives retinoic acid resistance of variant acute promyelocytic leukemias

Mathilde Poplineau, Nadine Platet, Adrien Mazuel, Léonard Hérault, Lia N’Guyen, Shuhei Koide, Yaeko Nakajima-Takagi, Wakako Kuribayashi, Nadine Carbuccia, Loreen Haboub, Julien Vernerey, Motohiko Oshima, Daniel Birnbaum, Atsushi Iwama, Estelle Duprez

Blood (2022) 140 (22): 2358–2370.

https://doi.org/10.1182/blood.2022015668

Published: 2022

Includes: Supplemental data

Journal Articles

Single Cell Analyses Reveal a Non-Canonical EZH2 Activity As a Main Driver of Retinoic Acid Resistance in PLZF/Rara Leukemia

Mathilde Poplineau, Nadine Platet, Adrien Mazuel, Léonard Hérault, Shuhei Koide, Wakako Kuribayashi, Nadine Carbuccia, Lia N'Guyen, Julien Vernerey, Motohiko Oshima, Daniel Birnbaum, Christophe Lachaud, Atsushi Iwama, Estelle Duprez

Blood (2021) 138 (Supplement 1): 2205.

https://doi.org/10.1182/blood-2021-146777

Published: 2021

Journal Articles

Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers

Blood (2020) 136 (6): 698–714.

https://doi.org/10.1182/blood.2019003062

Published: 2020

Includes: Supplemental data

Journal Articles

EBV + diffuse large B-cell lymphoma associated with chronic inflammation expands the spectrum of breast implant–related lymphomas

Lénaïg Mescam, Vincent Camus, Jean-Marc Schiano, José Adélaïde, Jean-Michel Picquenot, Arnaud Guille, Marie Bannier, Philippe Ruminy, Pierre-Julien Viailly, Fabrice Jardin, Reda Bouabdallah, Isabelle Brenot-Rossi, Elodie Bohers, Cyrielle Robe, Camille Laurent, Daniel Birnbaum, Andrew Wotherspoon, Philippe Gaulard, Luc Xerri

Blood (2020) 135 (22): 2004–2009.

https://doi.org/10.1182/blood.2019003408

Published: 2020

Includes: Supplemental data

Journal Articles

Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant–associated ALCL

Blood (2020) 135 (5): 360–370.

https://doi.org/10.1182/blood.2019001904

Published: 2020

Includes: Supplemental data

Journal Articles

Cegal Protocol : Evaluation of the Feasibility of a Chemogenomic Approach to Identify Personalized Therapy for Relapse or Refractory AML Patients

Norbert Vey, MD PhD, Marie Anne Hospital, Aude Collignon, Yves Collette, Daniel Birnbaum, Aude Charbonnier, Bilal Mohty, MD, Evelyne D'Incan, Jerome Rey, Remy Castellano, Camille Montersino, Max Chaffanet, Nadine Carbuccia, Jose Adelaide, Benjamin Bouchacourt, Arnaud Guille

Blood (2018) 132 (Supplement 1): 1401.

https://doi.org/10.1182/blood-2018-99-119263

Published: 2018

Journal Articles

BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders

Blood (2013) 122 (18): 3169–3177.

https://doi.org/10.1182/blood-2012-11-469619

Published: 2013

Includes: Supplemental data

Journal Articles

BCOR Mutations Represent an Independent Factor of Poor Prognosis in Myelodysplastic Syndromes

Blood (2012) 120 (21): 1697.

https://doi.org/10.1182/blood.V120.21.1697.1697

Published: 2012

Journal Articles

Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes

Blood (2012) 119 (14): 3211–3218.

https://doi.org/10.1182/blood-2011-12-400994

Published: 2012

Includes: Supplemental data

Journal Articles

Pediatric mastocytosis–associated KIT extracellular domain mutations exhibit different functional and signaling properties compared with KIT-phosphotransferase domain mutations

Ying Yang, Sébastien Létard, Laurence Borge, Amandine Chaix, Katia Hanssens, Sophie Lopez, Marina Vita, Pascal Finetti, Daniel Birnbaum, François Bertucci, Sophie Gomez, Paulo de Sepulveda, Patrice Dubreuil

Blood (2010) 116 (7): 1114–1123.

https://doi.org/10.1182/blood-2009-06-226027

Published: 2010

Includes: Supplemental data

Journal Articles

TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs)

Blood (2009) 114 (15): 3285–3291.

https://doi.org/10.1182/blood-2009-04-215814

Published: 2009

Includes: Supplemental data

Journal Articles

Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome

Bruno Chetaille, François Bertucci, Pascal Finetti, Benjamin Esterni, Aspasia Stamatoullas, Jean Michel Picquenot, Marie Christine Copin, Frank Morschhauser, Olivier Casasnovas, Tony Petrella, Thierry Molina, Anne Vekhoff, Pierre Feugier, Reda Bouabdallah, Daniel Birnbaum, Daniel Olive, Luc Xerri

Blood (2009) 113 (12): 2765–3775.

https://doi.org/10.1182/blood-2008-07-168096

Published: 2009

Includes: Supplemental data

Journal Articles

Small lymphocytic lymphoma, marginal zone B-cell lymphoma, and mantle cell lymphoma exhibit distinct gene-expression profiles allowing molecular diagnosis

Blood (2004) 103 (7): 2727–2737.

https://doi.org/10.1182/blood-2003-06-2160

Published: 2004

Includes: Supplemental data

Journal Articles

FOP-FGFR1 tyrosine kinase, the product of a t(6;8) translocation, induces a fatal myeloproliferative disease in mice

Géraldine Guasch, Bénédicte Delaval, Christine Arnoulet, Min-Jue Xie, Luc Xerri, Danielle Sainty, Daniel Birnbaum, Marie-Josèphe Pébusque

Blood (2004) 103 (1): 309–312.

https://doi.org/10.1182/blood-2003-05-1690

Published: 2004

Journal Articles

Gene expression profiling of multiple myeloma reveals molecular portraits in relation to the pathogenesis of the disease

Florence Magrangeas, Valéry Nasser, Hervé Avet-Loiseau, Béatrice Loriod, Olivier Decaux, Samuel Granjeaud, François Bertucci, Daniel Birnbaum, Catherine Nguyen, Jean-Luc Harousseau, Régis Bataille, Rémi Houlgatte, Stéphane Minvielle

Blood (2003) 101 (12): 4998–5006.

https://doi.org/10.1182/blood-2002-11-3385

Published: 2003

Journal Articles

Endogenous retroviral sequence is fused to FGFR1 kinase in the 8p12 stem-cell myeloproliferative disorder with t(8;19)(p12;q13.3)

Géraldine Guasch, Cornel Popovici, Francine Mugneret, Max Chaffanet, Pierre Pontarotti, Daniel Birnbaum, Marie-Josèphe Pébusque

Blood (2003) 101 (1): 286–288.

https://doi.org/10.1182/blood-2002-02-0577

Published: 2003

Journal Articles

FGFR1 is fused to the centrosome-associated protein CEP110 in the 8p12 stem cell myeloproliferative disorder with t(8;9)(p12;q33)

Géraldine Guasch, Gary J. Mack, Cornel Popovici, Nicole Dastugue, Daniel Birnbaum, Jérome B. Rattner, Marie-Josèphe Pébusque

Blood (2000) 95 (5): 1788–1796.

https://doi.org/10.1182/blood.V95.5.1788.005k15_1788_1796

Published: 2000

Journal Articles

The t(6;8)(q27;p11) Translocation in a Stem Cell Myeloproliferative Disorder Fuses a Novel Gene, FOP, to Fibroblast Growth Factor Receptor 1

Cornel Popovici, Bin Zhang, Marie-José Grégoire, Philippe Jonveaux, Marina Lafage-Pochitaloff, Daniel Birnbaum, Marie-Josèphe Pébusque

Blood (1999) 93 (4): 1381–1389.

https://doi.org/10.1182/blood.V93.4.1381

Published: 1999

Journal Articles

Functional and Phenotypic Characterization of Cord Blood and Bone Marrow Subsets Expressing FLT3 (CD135) Receptor Tyrosine Kinase

Irene Rappold, Benedikt L. Ziegler, Iris Köhler, Sylvie Marchetto, Olivier Rosnet, Daniel Birnbaum, Paul J. Simmons, Andrew C.W. Zannettino, Beth Hill, Stefan Neu, Walter Knapp, Riitta Alitalo, Kari Alitalo, Axel Ullrich, Lothar Kanz, Hans-Jörg Bühring

Blood (1997) 90 (1): 111–125.

https://doi.org/10.1182/blood.V90.1.111

Published: 1997

NARROW

Dasatinib Overcomes AML Resistance to BCL2 Inhibition By Indirectly Inhibiting MCL1: From Ex Vivo drug Sensitivity/Resistance Profiling to a Phase II Clinical Trial: A Hemato-BIO Study

Noncanonical EZH2 drives retinoic acid resistance of variant acute promyelocytic leukemias

Single Cell Analyses Reveal a Non-Canonical EZH2 Activity As a Main Driver of Retinoic Acid Resistance in PLZF/Rara Leukemia

Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers

EBV + diffuse large B-cell lymphoma associated with chronic inflammation expands the spectrum of breast implant–related lymphomas

Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant–associated ALCL

Cegal Protocol : Evaluation of the Feasibility of a Chemogenomic Approach to Identify Personalized Therapy for Relapse or Refractory AML Patients

BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders

BCOR Mutations Represent an Independent Factor of Poor Prognosis in Myelodysplastic Syndromes

Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes

Pediatric mastocytosis–associated KIT extracellular domain mutations exhibit different functional and signaling properties compared with KIT-phosphotransferase domain mutations

TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs)

Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome

Small lymphocytic lymphoma, marginal zone B-cell lymphoma, and mantle cell lymphoma exhibit distinct gene-expression profiles allowing molecular diagnosis

FOP-FGFR1 tyrosine kinase, the product of a t(6;8) translocation, induces a fatal myeloproliferative disease in mice

Gene expression profiling of multiple myeloma reveals molecular portraits in relation to the pathogenesis of the disease

Endogenous retroviral sequence is fused to FGFR1 kinase in the 8p12 stem-cell myeloproliferative disorder with t(8;19)(p12;q13.3)

FGFR1 is fused to the centrosome-associated protein CEP110 in the 8p12 stem cell myeloproliferative disorder with t(8;9)(p12;q33)

The t(6;8)(q27;p11) Translocation in a Stem Cell Myeloproliferative Disorder Fuses a Novel Gene, FOP, to Fibroblast Growth Factor Receptor 1

Functional and Phenotypic Characterization of Cord Blood and Bone Marrow Subsets Expressing FLT3 (CD135) Receptor Tyrosine Kinase

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only